FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] as First Treatment for Peanut Allergy BRISBANE, Calif.–(BUSINESS WIRE)–Jan. 31, 2020– Aimmune…
Home »
FDA committee: Makena should be removed from market
Makena, a drug used to reduce the risk for preterm births, should be taken off the U.S. market, a U.S.…
Here are the drugs the FDA says are OK to take in place of recalled Zantac
Walmart joins other retailers in removing the antacid Zantac from stores, ATM fees reach record high Fox Business Briefs: Stores…
Medtronic recalls some insulin pumps as FDA warns they could be hacked
(HealthDay)—The U.S. Food and Drug Administration announced Thursday that some high-tech insulin pumps made by Medtronic are being recalled for…
Moleculin Files with FDA for Expedited Approval Pathway for Annamycin
HOUSTON, TX / ACCESSWIRE / March 13, 2019 / Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical…
Q&A: Do opioids actually help with chronic pain? The FDA wants to know
Scott Gottlieb, commissioner of the Food and Drug Administration, told The Washington Post this week that his agency will require…
CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that the U.S. Food and…
FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection
KENILWORTH, N.J.–(BUSINESS WIRE) February 19, 2019 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced…
FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
THURSDAY, Feb. 7, 2019 — There has been an increase in the number of U.S. women diagnosed with a cancer…
FDA Approves Jeuveau
NEWPORT BEACH, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) — Evolus, Inc. (NASDAQ: EOLS) today announced that the U.S. Food and…